Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications understanding treatment preferences patients kras pg12clc1 mk2 ��� mutated advanced non
… across multiple therapeutic areas that include NAFLD (non-alcoholic fatty liver disease), diabetes, respiratory …
… site, operated out of the U.S., for sharing documents and non-personal or anonymized data between RTI and your …
… Citalopram and mirtazapine were used as first-line treatment, and agomelatine and duloxetine were used as second-line treatment. Based on the results of the study, we concluded …
… a range of therapeutic areas, including multiple myeloma, non-alcoholic steatohepatitis, congenital cytomegalovirus …
ENCePP Pharmacoepidemiology Methodological Standards Guide Revision 9 Released Share on: July 16, 2021 The ENCePP Guide on Methodological Standards in Pharmacoepidemiology was created and is maintained by members of the European Network of Centres for …
… View Now Generating and communicating evidence in COVID-19 treatment and vaccine development Although COVID-19-related … While companies race to be at the forefront of vaccine and treatment development, current strategies for evidence …
… State University, San Diego, CA BS, Biology Certificate of Advanced Business Studies California State University, …
EMA Selects Research Collaboration to Prepare for Rapid Assessment Of COVID-19 Vaccine Effects Post-Approval Share on: June 29, 2020 In advance of an approved COVID-19 vaccine, the European Medicines Agency (EMA) has commissioned research to monitor any …
Regulatory Guidance and Support We can support you throughout your regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of reviewing divisions on numerous occasions to select and …
… dealt with the current regulation for the conduct of non-interventional studies in France. …